Goldman Sachs’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Buy |
|
|||||
|
2025
Q1 | $10.4M | Buy |
|
|||||
|
2024
Q4 | $14.8M | Sell |
|
|||||
|
2024
Q3 | $24.1M | Sell |
|
|||||
|
2024
Q2 | $74M | Buy |
|
|||||
|
2024
Q1 | $47.2M | Buy |
|
|||||
|
2023
Q4 | $15.4M | Sell |
|
|||||
|
2023
Q3 | $13.5M | Sell |
|
|||||
|
2023
Q2 | $22.6M | Buy |
|
|||||
|
2023
Q1 | $17.2M | Buy |
|
|||||
|
2022
Q4 | $9.69M | Buy |
|
|||||
|
2022
Q3 | $5.05M | Buy |
|
|||||
|
2022
Q2 | $454K | Sell |
|
|||||
|
2022
Q1 | $757K | Sell |
|
|||||
|
2021
Q4 | $1.01M | Buy |
|
|||||
|
2021
Q3 | $637K | Sell |
|
|||||
|
2021
Q2 | $3.83M | Buy |
|
|||||
|
2021
Q1 | $1.59M | Buy |
|
|||||
|
2020
Q4 | $939K | Sell |
|
|||||
|
2020
Q3 | $3.59M | Buy |
|